Since the implementation of ACA, Florida Blue’s enrollment plans have changed in that plan has expanded its outreach platforms and had to educate a larger audience of consumers, explained Anne Jessup, senior director of digital channels at Florida Blue.
Since the implementation of ACA, Florida Blue’s enrollment plans have changed in that plan has expanded its outreach platforms and had to educate a larger audience of consumers, explained Anne Jessup, senior director of digital channels at Florida Blue.
Transcript (modified)
How has Florida Blue’s enrollment plans changed with the implementation of the ACA? And how have they evolved over the first 3 years of ACA open enrollment?
Florida has a slightly unique position regarding the individual market. We’ve had a strong presence in the individual market since late 2008-2009. We started engaging consumers on a one-to-one basis, actively in the community, wholeheartedly in 2010. We opened retail centers around the state, as well as promoted our contracted general agents, the broker communities, to really establish footholds in the community—encouraging events, encouraging different activities that really connected them to the members and to the community folks at large.
Using that platform, and expanding it even further with the start of open enrollment for 2014, was a huge opportunity for us. It has changed things, though. Prior to ACA, we really weren’t an individual market that focused on people who could qualify for coverage as well as who could pay for the coverage. Coming into that first 2014 open enrollment period, it shifted. We had a new target audience: a group of consumers who weren’t as well-educated and potentially weren’t financially sound, and really came not knowing much about insurance.
So the shift of really having to educate them, not only about the benefits but about how a health plan works, how they can make a smart choice, and how they can really use those benefits for themselves and their families.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More